Literature DB >> 19605646

Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.

Xinglong Wang1, Bo Su, Hyoung-gon Lee, Xinyi Li, George Perry, Mark A Smith, Xiongwei Zhu.   

Abstract

Mitochondrial dysfunction is a prominent feature of Alzheimer's disease (AD) neurons. In this study, we explored the involvement of an abnormal mitochondrial dynamics by investigating the changes in the expression of mitochondrial fission and fusion proteins in AD brain and the potential cause and consequence of these changes in neuronal cells. We found that mitochondria were redistributed away from axons in the pyramidal neurons of AD brain. Immunoblot analysis revealed that levels of DLP1 (also referred to as Drp1), OPA1, Mfn1, and Mfn2 were significantly reduced whereas levels of Fis1 were significantly increased in AD. Despite their differential effects on mitochondrial morphology, manipulations of these mitochondrial fission and fusion proteins in neuronal cells to mimic their expressional changes in AD caused a similar abnormal mitochondrial distribution pattern, such that mitochondrial density was reduced in the cell periphery of M17 cells or neuronal process of primary neurons and correlated with reduced spine density in the neurite. Interestingly, oligomeric amyloid-beta-derived diffusible ligands (ADDLs) caused mitochondrial fragmentation and reduced mitochondrial density in neuronal processes. More importantly, ADDL-induced synaptic change (i.e., loss of dendritic spine and postsynaptic density protein 95 puncta) correlated with abnormal mitochondrial distribution. DLP1 overexpression, likely through repopulation of neuronal processes with mitochondria, prevented ADDL-induced synaptic loss, suggesting that abnormal mitochondrial dynamics plays an important role in ADDL-induced synaptic abnormalities. Based on these findings, we suggest that an altered balance in mitochondrial fission and fusion is likely an important mechanism leading to mitochondrial and neuronal dysfunction in AD brain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19605646      PMCID: PMC2735241          DOI: 10.1523/JNEUROSCI.1357-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

Review 1.  Mitochondria and neuronal activity.

Authors:  Oliver Kann; Richard Kovács
Journal:  Am J Physiol Cell Physiol       Date:  2006-11-08       Impact factor: 4.249

2.  Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission.

Authors:  Naoko Taguchi; Naotada Ishihara; Akihiro Jofuku; Toshihiko Oka; Katsuyoshi Mihara
Journal:  J Biol Chem       Date:  2007-02-14       Impact factor: 5.157

3.  Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.

Authors:  Pascale N Lacor; Maria C Buniel; Paul W Furlow; Antonio Sanz Clemente; Pauline T Velasco; Margaret Wood; Kirsten L Viola; William L Klein
Journal:  J Neurosci       Date:  2007-01-24       Impact factor: 6.167

4.  AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.

Authors:  Helen Hsieh; Jannic Boehm; Chihiro Sato; Takeshi Iwatsubo; Taisuke Tomita; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2006-12-07       Impact factor: 17.173

5.  Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons.

Authors:  Yanfang Rui; Priyanka Tiwari; Zuoping Xie; James Q Zheng
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

6.  Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease.

Authors:  E Masliah; M Mallory; M Alford; R DeTeresa; L A Hansen; D W McKeel; J C Morris
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

7.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

8.  Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.

Authors:  C Delettre; G Lenaers; J M Griffoin; N Gigarel; C Lorenzo; P Belenguer; L Pelloquin; J Grosgeorge; C Turc-Carel; E Perret; C Astarie-Dequeker; L Lasquellec; B Arnaud; B Ducommun; J Kaplan; C P Hamel
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

9.  Mitochondrial bioenergetics and structural network organization.

Authors:  Giovanni Benard; Nadège Bellance; Dominic James; Philippe Parrone; Helder Fernandez; Thierry Letellier; Rodrigue Rossignol
Journal:  J Cell Sci       Date:  2007-02-13       Impact factor: 5.285

10.  Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.

Authors:  Nicole Exner; Bettina Treske; Dominik Paquet; Kira Holmström; Carola Schiesling; Suzana Gispert; Iria Carballo-Carbajal; Daniela Berg; Hans-Hermann Hoepken; Thomas Gasser; Rejko Krüger; Konstanze F Winklhofer; Frank Vogel; Andreas S Reichert; Georg Auburger; Philipp J Kahle; Bettina Schmid; Christian Haass
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

View more
  492 in total

Review 1.  Are tangles as toxic as they look?

Authors:  Tara L Spires-Jones; Katherine J Kopeikina; Robert M Koffie; Alix de Calignon; Bradley T Hyman
Journal:  J Mol Neurosci       Date:  2011-06-03       Impact factor: 3.444

2.  Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort.

Authors:  Anita Lakatos; Olga Derbeneva; Danny Younes; David Keator; Trygve Bakken; Maria Lvova; Marty Brandon; Guia Guffanti; Dora Reglodi; Andrew Saykin; Michael Weiner; Fabio Macciardi; Nicholas Schork; Douglas C Wallace; Steven G Potkin
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

3.  Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.

Authors:  Baiyang Sheng; Xinglong Wang; Bo Su; Hyoung-gon Lee; Gemma Casadesus; George Perry; Xiongwei Zhu
Journal:  J Neurochem       Date:  2011-12-08       Impact factor: 5.372

4.  Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid.

Authors:  Jia Yao; Ronald Irwin; Shuhua Chen; Ryan Hamilton; Enrique Cadenas; Roberta Diaz Brinton
Journal:  Neurobiol Aging       Date:  2011-04-22       Impact factor: 4.673

Review 5.  Control of mitochondrial activity by miRNAs.

Authors:  Peifeng Li; Jianqing Jiao; Guifeng Gao; Bellur S Prabhakar
Journal:  J Cell Biochem       Date:  2012-04       Impact factor: 4.429

Review 6.  Mitochondrial morphology-emerging role in bioenergetics.

Authors:  Chad A Galloway; Hakjoo Lee; Yisang Yoon
Journal:  Free Radic Biol Med       Date:  2012-09-29       Impact factor: 7.376

Review 7.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Diazoxide pretreatment prevents Aβ1-42 induced oxidative stress in cholinergic neurons via alleviating NOX2 expression.

Authors:  Qingxi Fu; Naiyong Gao; Jixu Yu; Guozhao Ma; Yifeng Du; Fumin Wang; Quanping Su; Fengyuan Che
Journal:  Neurochem Res       Date:  2014-04-27       Impact factor: 3.996

9.  Bax interacting factor-1 promotes survival and mitochondrial elongation in neurons.

Authors:  David B Wang; Takuma Uo; Chizuru Kinoshita; Bryce L Sopher; Rona J Lee; Sean P Murphy; Yoshito Kinoshita; Gwenn A Garden; Hong-Gang Wang; Richard S Morrison
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

10.  Effects of Al Exposure on Mitochondrial Dynamics in Rat Hippocampus.

Authors:  Jisheng Nie; Shengjie Lv; Xueying Fu; Qiao Niu
Journal:  Neurotox Res       Date:  2019-05-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.